TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
AGC Biologics A/S
Closing information (x1000 EUR)
Closing information | 2021/12 | 2020/12 | 2019/12 |
Turnover | 293,833 | 195,590 | 133,357 |
Earnings before taxes | 98,713 | 48,004 | 26,523 |
Total assets | 422,342 | 315,555 | 158,297 |
Current assets | 284,072 | 216,562 | 83,661 |
Current liabilities | 253,168 | 179,162 | 94,902 |
Equity capital | 85,202 | 45,659 | 28,802 |
- share capital | 5,763 | 5,760 | 5,737 |
Employees (average) | 350 | 350 | 350 |
Financial ratios
Fiscal year | 2021/12 | 2020/12 | 2019/12 |
Solvency | 20.2% | 14.5% | 18.2% |
Turnover per employee | 840 | 559 | 381 |
Profit as a percentage of turnover | 33.6% | 24.5% | 19.9% |
Return on assets (ROA) | |||
Current ratio | 112.2% | 120.9% | 88.2% |
Return on equity (ROE) | 115.9% | 105.1% | 92.1% |
Change turnover | 98,162 | 61,690 | 40,634 |
Change turnover % | 50% | 46% | 44% |
Chg. No. of employees | 0 | 0 | 0 |
Chg. No. of employees % | 0% | 0% | 0% |
Total value of public sale
Fiscal year | 2021/12 | 2020/12 | 2019/12 |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.